Division of Allergy Pulmonary and Critical Care Medicine

An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management. (photo by Joe Howell)
December 2, 2025

Ketamine fails surgical recovery trial

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.

By Paul Govern
The team studying how to control sepsis in the lungs and kidneys includes, from left, Huan Qiao, MD, PhD Jacek Hawiger, MD, PhD, Jozef Zienkiewicz, PhD, and Yan Liu, MD, MS. (photo by Erin O. Smith)
October 22, 2025

New sepsis therapy developed at VUMC edges closer to the clinic

Jacek Hawiger and his colleagues report that a “peptide genomic therapy” given in combination with an antibiotic nearly doubles survival rates from sepsis in an animal model, compared to treatment with antibiotic alone.

By Bill Snyder
September 11, 2025

Stokes Peebles steps down as section chief of Allergy after 15 Years of leadership

During his tenure, he grew the section into a nationally recognized center for excellence in clinical care, research and education.

By Kylie Avery
Scott McCall, MD, PhD
May 20, 2025

Lung researchers at VUMC win prestigious fellowships

They are Scott McCall, MD, PhD, instructor in Medicine, and Kevin Seitz, MD, MSc, assistant professor of Medicine.

By Bill Snyder
(iStock image)
May 18, 2025

Study finds navigational bronchoscopy as effective and safer alternative to transthoracic biopsy for lung nodules  

Each year, millions of lung nodules are detected during routine X-rays or CT scans.

By Craig Boerner and Holly Fletcher 
(iStock)
March 11, 2025

Thinking outside the (voice) box: VUMC surgeons have all the pieces in place for the complex puzzle of laryngeal transplantation 

Only a few laryngeal transplants have been successfully performed in the United States. Now, surgeons at Vanderbilt University Medical Center are ready for their first patient.

By Evan Dorian
February 14, 2025

VUMC honors four translational scientists

Translational research brings discoveries from the laboratory and preclinical studies to clinical trials and studies in humans.
By Bill Snyder
February 3, 2025

VUMC study takes closer look at how pulmonary fibrosis unfolds

The research could point to future therapeutic strategies that treat PF patients based on their individual stage of cellular and molecular remodeling.
By Nancy Humphrey
January 14, 2025

Two VUMC physician-scientists named to medical honor society

They are among more than 3,500 ASCI members, 48 of whom are current, full-time faculty members of the Vanderbilt University School of Medicine.
By Bill Snyder
January 8, 2025

Study suggests a new way to treat incurable lung disease

IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the airways.
By Bill Snyder
December 20, 2024

Vanderbilt Center for Transplant Science announces leadership team 

The center was created earlier this year to save the lives of patients waiting for a transplant and improve outcomes for patients after they receive a transplant.
By Doug Campbell
December 16, 2024

VUMC awarded $26.4 million for patient-centered research

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.
By Bill Snyder
December 5, 2024

VUMC to study effect of breathing tube size on breathing, speaking, swallowing

Approximately 1% of the U.S. population — 2 million to 3 million adults — experience critical illness requiring the placement of a breathing tube each year.
By Nancy Humphrey
1 2 3 … 12